| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Kastenbauer, Koedel, and Pfister), Klinikum Grosshadern; and Department of Physiology (Dr. Becker), Ludwig-Maximilians University, Munich, Germany.
Address correspondence and reprint requests to Dr. Hans Walter Pfister, Department of Neurology, Ludwig-Maximilians University, Marchioninistr. 15, 81377 Munich, Germany; e-mail: Pfister{at}nefo.med.uni-muenchen.de
Objective: To study reactive nitrogen species–mediated oxidative brain damage and antioxidant defenses in patients with acute bacterial meningitis.
Methods: Nitrotyrosine (a widely used marker for the formation of reactive nitrogen species, such as peroxynitrite) and the lipid peroxidation product 4-hydroxynonenal were detected by immunohistochemistry in brain specimens obtained at autopsy. CSF concentrations of nitrotyrosine were quantified by ELISA. CSF and serum concentrations of ascorbic acid, uric acid, and its oxidation product allantoin were determined by high-pressure liquid chromatography.
Results: Tyrosine nitration was strongly increased during meningitis. It was most evident in inflammatory cells and blood vessels in the subarachnoid space. The same cell types stained positive for the lipid peroxidation marker 4-hydroxynonenal, suggesting that reactive nitrogen species contribute to oxidative brain damage during meningitis. High CSF nitrotyrosine concentrations were associated with an unfavorable outcome according to the Glasgow Outcome Score. In the CSF, the increase of nitrotyrosine was accompanied by a depletion of the antioxidant ascorbic acid and an increased oxidation of the natural peroxynitrite scavenger uric acid to allantoin.
Conclusion: These findings indicate that oxidative stress due to reactive nitrogen species and altered antioxidant defenses are involved in the pathophysiology of bacterial meningitis in humans.
This article has been cited by other articles:
|
|
 |
|
  W. B. Gerritsen, W.-J. P. van Boven, D. S. Boss, F. J. Haas, E. P. van Dongen, and L. P. Aarts Malondialdehyde in plasma, a biomarker of global oxidative stress during mini-CABG compared to on- and off-pump CABG surgery: a pilot study Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 27 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Papadopoulos and A. S. Verkman Aquaporin-4 Gene Disruption in Mice Reduces Brain Swelling and Mortality in Pneumococcal Meningitis J. Biol. Chem., April 8, 2005; 280(14): 13906 - 13912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Chou, C.-Z. Lee, L.-C. Ma, C.-T. Fang, S.-C. Chang, and J.-T. Wang Isolation of a Chromosomal Region of Klebsiella pneumoniae Associated with Allantoin Metabolism and Liver Infection Infect. Immun., July 1, 2004; 72(7): 3783 - 3792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-m. Tsao, C.-c. Hsu, and M.-c. Yin Garlic extract and two diallyl sulphides inhibit methicillin-resistant Staphylococcus aureus infection in BALB/cA mice J. Antimicrob. Chemother., December 1, 2003; 52(6): 974 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. van der Flier, S. P. M. Geelen, J. L. L. Kimpen, I. M. Hoepelman, and E. I. Tuomanen Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome? Clin. Microbiol. Rev., July 1, 2003; 16(3): 415 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Winkler, S. Kastenbauer, U. Koedel, and H. W. Pfister Role of the urokinase plasminogen activator system in patients with bacterial meningitis Neurology, November 12, 2002; 59(9): 1350 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Simon and J. S. Beckman Why pus is bad for the brain Neurology, January 22, 2002; 58(2): 167 - 168. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
